Kirkland & Ellis and Advestra advised Will Semiconductor Co., Ltd. Shanghai on the offering. Clifford Chance and Niederer Kraft Frey advised J.P. Morgan Securities plc and...
Will Semiconductor Co.’s $444.9 Million GDR Offering and Listing on SIX Swiss Exchange
ZX Inc.’s HK$266 Million Hong Kong IPO
Kirkland & Ellis, Beijing Dacheng Law Offices, LLP, Goldsun Law Firm and Walkers (Hong Kong) represented ZX Inc., and Wilson Sonsini Goodrich & Rosati and JunHe...
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Bain Capital Private Equity’s $400 Million Equity Investment in EcoCeres
Kirkland & Ellis advised Bain Capital Private Equity on the deal. Bain Capital Private Equity announced its significant equity investment in EcoCeres. EcoCeres is incubated by The Hong...
Super Hi’s Spin-off and Separate Listing
Kirkland & Ellis advised on Hong Kong law, Jingtian & Gongcheng advised on PRC law, Conyers Dill & Pearman advised on Cayman Islands law, Drew &...
Suzhou Ribo Life Science’s $40 Million Series E1 Financing Round
Kirkland & Ellis advised Suzhou Ribo Life Science Co., Ltd. on the transaction. Suzhou Ribo Life Science Co., Ltd. (Ribo), a clinical stage company developing innovative...
Noah Holdings’ Secondary Listing on HKSE
Freshfields Bruckhaus Deringer advised Goldman Sachs on the deal. Kirkland & Ellis and Zhong Lun represented Noah Holdings Limited. The deal concerns the SEC-registered offering and...
Joy Spreader Group’s $77.5 Million Top-up Share Placement
Kirkland & Ellis advised Joy Spreader Group on the deal. Joy Spreader Group Inc. (HKSE: 6988), a leading China-based marketing technology company, on the raising of...
Yunkang Group Limited’s $140 Million Hong Kong Listing
Kirkland & Ellis and Zhong Lun advised Yunkang Group Limited on the deal. Herbert Smith Freehills advised CMB International Capital Limited and SPDB International Capital Limited....
Recbio Technology Co., Ltd.’s US$98 Million Initial Public Offering
Kirkland & Ellis advised Jiangsu Recbio Technology Co., Ltd., while Clifford Chance has advised the joint sponsors and underwriters involved in the deal. Recbio Technology Co.,...
Arrail Group Limited’s US$88 Million Initial Public Offering
Harneys acted as British Virgin Islands and Cayman Islands counsel for the successful listing of the shares of Arrail Group Limited on the Main Board of...
CANbridge Pharmaceuticals Inc.’s HK$604 Million IPO
Harneys, alongside Davis Polk & Wardwell and King & Wood Mallesons, acted as Cayman Islands counsel to CANbridge Pharmaceuticals Inc. Kirkland & Ellis and Tian Yuan...